Why BHTS Immunotherapy Stands as the Best Choice for Targeted Healing
Types of Cancer Treated With Immunotherapy
Immunotherapy is an innovative approach to cancer treatment that harnesses the body's immune system to fight cancer.
Why Choose Immunotherapy
Choosing immunotherapy means opting for a treatment that not only targets cancer more effectively but also supports overall health and long-term recovery.
Treatment Development
Treatment development transforms scientific research into safe and effective therapies. It starts with identifying treatment targets, followed by preclinical testing. Next, clinical trials assess safety and effectiveness. If successful, the treatment gains regulatory approval and is made available to patients, with ongoing monitoring to ensure long-term safety.
Discovery and Preclinical Research
Scientists identify the biological mechanisms of cancer and potential targets for therapy. This involves basic research, preclinical testing, and the development of a lead compound, ensuring that the treatment is safe and effective before moving forward.
Clinical Trials
The treatment is tested in humans across three phases: Phase I for safety, Phase II for efficacy, and Phase III for comparison with existing treatments. Success in these trials is crucial for moving toward regulatory approval.
Regulatory Approval
Once clinical trials are successful, the treatment undergoes regulatory approval where detailed data on its safety, efficacy, and manufacturing process are submitted to agencies like the FDA. Approval allows the treatment to be prescribed and marketed for patient use.
Post Market Surveillance
Ensures the treatment's long-term safety and effectiveness, while ongoing research may lead to further improvements or new applications. As the treatment is integrated into clinical practice, patients and healthcare providers are educated about its use.
Patient Care and Support at BHTS Immunotherapy
At BHTS Immunotherapy, we are committed to providing exceptional care and comprehensive support to our patients throughout their cancer treatment journey. Our approach is centered on personalized care, ensuring that each patient receives the attention and resources they need for the best possible outcomes.
our work
Key Metrics for Four Major Immunotherapy Treatments: Response Rate, 1-Year Survival, and 6-Month PFS
The graph uses three distinct colors to clearly differentiate between the various data sets
Response Rate %
1-Year Overall Survival Rate %
PFS at 6 Months %
